IGMS
$5.08
Revenue | $0.51Mn |
Net Profits | $-61.99Mn |
Net Profit Margins | -12178.59% |
Igm Biosciences Inc’s revenue jumped 53.78% since last year same period to $0.51Mn in the Q3 2023. On a quarterly growth basis, Igm Biosciences Inc has generated 13.62% jump in its revenue since last 3-months.
Igm Biosciences Inc’s net profit fell -11.57% since last year same period to $-61.99Mn in the Q3 2023. On a quarterly growth basis, Igm Biosciences Inc has generated 3.78% jump in its net profits since last 3-months.
Igm Biosciences Inc’s net profit margin jumped 27.45% since last year same period to -12178.59% in the Q3 2023. On a quarterly growth basis, Igm Biosciences Inc has generated 15.31% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -1.1 |
EPS Estimate Current Year | -1.1 |
Igm Biosciences Inc’s earning per share (EPS) estimates for the current quarter stand at -1.1 - a 9.09% jump from last quarter’s estimates.
Igm Biosciences Inc’s earning per share (EPS) estimates for the current year stand at -1.1.
Earning Per Share (EPS) | -1.04 |
Igm Biosciences Inc’s earning per share (EPS) jumped 21.21% since last year same period to -1.04 in the Q3 2023. This indicates that the Igm Biosciences Inc has generated 21.21% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-08-03 | -1.43 | -1.43 | 0% |
2023-11-13 | -1.21 | -1.04 | 14.05% |
2023-05-12 | -1.36 | -1.33 | 2.21% |